Text Size

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

This study has been completed.
Sponsor:
Information provided by:
Baqiyatallah Medical Sciences University
ClinicalTrials.gov Identifier:
NCT00512811
First received: August 7, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure


Condition Intervention Phase
Bronchiolitis
 Drug: furosemide
 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Baqiyatallah Medical Sciences University:

Primary Outcome Measures:
  • effect of furosemid inhalation on dyspnea

  Eligibility

Ages Eligible for Study:   32 Years to 83 Years
Genders Eligible for Study:   Male
Criteria

Inclusion Criteria:

  • Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

  • A contraindication for furosemide use;
  • An accompanying disease in which other drugs effective for dyspnea were used
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00512811

Locations
Iran, Islamic Republic of
RCCI
Tehran, Iran, Islamic Republic of
Sponsors and Collaborators
Baqiyatallah Medical Sciences University
Investigators
Study Chair: Mostafa Ghanei, MD Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00512811     History of Changes
Other Study ID Numbers: 121a25
Study First Received: August 7, 2007
Last Updated: August 7, 2007
Health Authority: Iran: Ethics Committee

Keywords provided by Baqiyatallah Medical Sciences University:
furosemide
inhalation
dyspnea
spirometry
 mustard gas
bronchiolitis
sulfur mustard

Additional relevant MeSH terms:
Respiratory Aspiration
Bronchiolitis
Dyspnea
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Bronchitis
Bronchial Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections
 Furosemide
Mustard Gas
Sodium Potassium Chloride Symporter Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Diuretics
Natriuretic Agents
Physiological Effects of Drugs
Cardiovascular Agents
Therapeutic Uses
Dermatologic Agents

ClinicalTrials.gov processed this record on June 17, 2013